Definium Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $164.0M
Liabilities Breakdown FY2021
Total Liabilities: $12.3M
Asset Breakdown
Total Assets: $164.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $133.5M | 81.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $19.9M | 12.1% |
| Intangible Assets | $6.9M | 4.2% |
| Other Assets | $3.7M | 2.2% |
Liabilities Breakdown
Total Liabilities: $12.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.2M | 33.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $8.2M | 66.1% |